Healthcor Management LP Has Lowered Bard C R (BCR) Position By $20.75 Million; Ormat Technologies (ORA) Has 1.49 Sentiment

June 19, 2017 - By Louis Casey

Healthcor Management Lp decreased Bard C R Inc (BCR) stake by 46.32% reported in 2016Q4 SEC filing. Healthcor Management Lp sold 92,630 shares as Bard C R Inc (BCR)’s stock rose 26.87%. The Healthcor Management Lp holds 107,370 shares with $24.12 million value, down from 200,000 last quarter. Bard C R Inc now has $22.80B valuation. The stock rose 0.51% or $1.58 reaching $315.14. About 380,536 shares traded. C R Bard Inc (NYSE:BCR) has risen 40.70% since June 19, 2016 and is uptrending. It has outperformed by 24.00% the S&P500.

Ormat Technologies, Inc. is engaged in the geothermal and recovered energy power business. The company has market cap of $3.00 billion. The Firm designs, develops, builds, owns and operates geothermal and recovered energy power plants. It has a 30.42 P/E ratio. The Company’s equipment manufacturing activities are located in Israel.

Ion Asset Management Ltd. holds 4.56% of its portfolio in Ormat Technologies, Inc. for 201,246 shares. Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) owns 728,326 shares or 3.14% of their US portfolio. Moreover, Mitchell Capital Management Co has 2.4% invested in the company for 118,022 shares. The Israel-based Clal Insurance Enterprises Holdings Ltd has invested 2.01% in the stock. Friedberg Investment Management, a Texas-based fund reported 79,490 shares.

About 83,607 shares traded. Ormat Technologies, Inc. (ORA) has risen 34.71% since June 19, 2016 and is uptrending. It has outperformed by 18.01% the S&P500.

Since January 1, 0001, it had 0 buys, and 11 sales for $3.78 million activity.

Healthcor Management Lp increased Collegium Pharmaceutical Inc stake by 26,300 shares to 1.43M valued at $22.21M in 2016Q4. It also upped Hca Holdings Inc (NYSE:HCA) stake by 67,520 shares and now owns 157,260 shares. Incyte Corp (NASDAQ:INCY) was raised too.

Investors sentiment decreased to 0.8 in 2016 Q4. Its down 0.01, from 0.81 in 2016Q3. It turned negative, as 44 investors sold BCR shares while 235 reduced holdings. 61 funds opened positions while 163 raised stakes. 62.78 million shares or 0.00% less from 62.78 million shares in 2016Q3 were reported. Healthcor Management Lp has 1.36% invested in C R Bard Inc (NYSE:BCR). New Jersey-based Kcg has invested 0.02% in C R Bard Inc (NYSE:BCR). Idaho-based Buffington Mohr Mcneal has invested 0.57% in C R Bard Inc (NYSE:BCR). The Hawaii-based Retail Bank Of Hawaii has invested 0.07% in C R Bard Inc (NYSE:BCR). Neville Rodie & Shaw Inc invested in 0.04% or 1,550 shares. Virtu Financial Llc holds 0.04% of its portfolio in C R Bard Inc (NYSE:BCR) for 1,464 shares. Invest House Lc owns 13,160 shares. Henderson Grp Plc invested in 213,880 shares. Murphy Cap Management holds 0.18% or 5,146 shares. Foster & Motley holds 4,528 shares. Asset Mgmt Inc invested 0.04% of its portfolio in C R Bard Inc (NYSE:BCR). Independent Portfolio Consultants, a Florida-based fund reported 65 shares. Moreover, Retirement Sys Of Alabama has 0.05% invested in C R Bard Inc (NYSE:BCR) for 35,869 shares. Pension Ser reported 60,307 shares. Incorporated accumulated 24,511 shares.

Analysts await C R Bard Inc (NYSE:BCR) to report earnings on July, 25. They expect $2.82 EPS, up 10.16% or $0.26 from last year’s $2.56 per share. BCR’s profit will be $204.02 million for 27.94 P/E if the $2.82 EPS becomes a reality. After $2.87 actual EPS reported by C R Bard Inc for the previous quarter, Wall Street now forecasts -1.74% negative EPS growth.

Among 13 analysts covering CR Bard (NYSE:BCR), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. CR Bard had 23 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of C R Bard Inc (NYSE:BCR) has “Outperform” rating given on Friday, September 16 by Wells Fargo. Morgan Stanley upgraded the shares of BCR in report on Tuesday, January 3 to “Overweight” rating. Raymond James maintained the stock with “” rating in Wednesday, April 26 report. KeyBanc Capital Markets initiated C R Bard Inc (NYSE:BCR) on Thursday, August 27 with “Sector Weight” rating. The company was downgraded on Wednesday, April 26 by BMO Capital Markets. The firm has “Market Perform” rating given on Wednesday, April 26 by Wells Fargo. The stock of C R Bard Inc (NYSE:BCR) has “Neutral” rating given on Thursday, August 27 by Goldman Sachs. The stock has “Buy” rating by BMO Capital Markets on Wednesday, April 12. On Wednesday, July 27 the stock rating was maintained by Citigroup with “Buy”. The firm has “Buy” rating by Citigroup given on Thursday, November 12.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: